Does intravitreal injection of bevacizumab have an effect on the blood-aqueus barrier function?
- 1 July 2006
- journal article
- letter
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (7) , 922
- https://doi.org/10.1136/bjo.2006.092262
Abstract
Blood-aqueous barrier (BAB) breakdown has been reported after intraocular application of lyophilised rhuFab formulations.3 Anterior chamber inflammation is one of the most frequently reported adverse events (19%) after pegaptanib injections.4 We wanted to post these safety issues for bevacizumab by objective detection of aqueous protein concentration.Keywords
This publication has 5 references indexed in Scilit:
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Regulation of vascular permeability by vascular endothelial growth factorsVascular Pharmacology, 2002
- Anterior chamber flare after trabeculectomy and after phacoemulsificationBritish Journal of Ophthalmology, 2000
- Laser tyndallometry in anterior segment diseases.1994
- Measurement of aqueous cells and flare in normal eyes.British Journal of Ophthalmology, 1991